Navigation Links
Potential New Cancer Gene Identified

A Johns Hopkins University research team has discovered a new family of genes that contributes to the process of malignancy, shedding new light on the abnormalities that give rise to the aggressive childhood cancer, Burkitt's lymphoma - as well as lymphoma, leukemia, prostate, ovarian, lung, and breast cancer.

Characterized by rapidly growing abdominal tumors, Burkitt's lymphoma is one of the three major types of pediatric non-Hodgkin's lymphomas, representing 40% of that group. According to the American Cancer Society, aproximately 57,000 children are diagnosed with non-Hodgkin's lymphoma per year in the United States, representing about 6% of cancers in children. While aggressive, Burkitt's lymphoma responds well to chemotherapy, and has a 90% survival rate if the tumor has not spread beyond the abdomen.

Scientists have long known that the "myc" family of genes plays a prominent role in tumor formation, also called neoplastic transformation. The Hopkins team, focusing on c-myc, found that another gene called the HMG-I/Y gene is a key genetic "target" necessary for Myc-mediated transformation.

When the expression of this target gene in Burkitt's lymphoma cell lines was blocked, the cancer cells revert back to normal-appearing cells. This could point the way to new therapies for one of the most aggressive childhood cancers, as well as other cancers associated with increases in the HMG-I/Y gene according to the Johns Hopkin's research team.
'"/>




Page: 1

Related medicine news :

1. Lack of Smell And Its Potential Risks
2. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
3. The Potential Of Cadaver Transplantation Programme In India
4. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
5. Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt
6. A Protein In Yoghurt Has The Potential To Fight E. coli
7. Gold Therapy- A Potential Treatment For Autoimmune Diseases
8. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
9. Potential Benefits Of New Nanotechnology
10. Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension
11. UC Researchers Find Potential Drug Target For SARS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... The V Foundation for Cancer ... a Moment to Lose fundraising campaign. As the V Foundation’s boldest initiative to ... over cancer. The campaign aims to raise $200 million by 2020 and strategically ...
(Date:12/6/2016)... ... December 06, 2016 , ... Just in time for the holiday ... chocolate chip cookie recipe for Honeyville’s new Organic Quinoa Flour product for sale at ... in the near future. , “I think it’s wonderful that a growing number ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... recount of a powerful woman's story of sacrifice and enlightenment. , ... published author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward writing ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has announced ... on providing occupational safety and health training to public sector employees. , “The ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016  CVS Health, the nation,s largest ... a perfect score of 100 percent on the Corporate ... CEI is an annual national benchmarking survey and report ... administered by the Human Rights Campaign Foundation. ... that our colleagues, customers and suppliers bring to CVS ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... founder of Spectrum Science Communications , announced today that ... two consecutive years of high double digit growth in fee revenues. ... assumed management of the firm that Seng founded in 1996. Earlier ... of the Year and was selected among the Best Places to ... ...
Breaking Medicine Technology: